Loading organizations...
Loading organizations...
Biotechnology company offering gene editing and personalized medicine.
Canopy Biosciences has raised $2.4M across 1 funding round.
Canopy Biosciences has raised $2.4M in total across 1 funding round.
Canopy Biosciences has raised $2.4M in total across 1 funding round.
Canopy Biosciences's investors include Charlie Bolten, Brandon K. Mann, Greenleaf Fund, Missouri Technology Corporation, PinPoint Holdings, St. Louis Arch Angels.
Canopy Biosciences has raised $2.4M across 1 funding round. Most recently, it raised $2.4M Series A in May 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 22, 2018 | $2.4M Series A | Charlie Bolten, Brandon K. Mann | Greenleaf Fund, Missouri Technology Corporation, PinPoint Holdings, St. Louis Arch Angels |